Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:19 PM
Ignite Modification Date:
2025-12-24 @ 4:19 PM
NCT ID:
NCT00851266
Eligibility Criteria:
Inclusion Criteria:
* Subject is in good physical health
* Subject is not in the category of individuals recommended by the CDC to receive influenza vaccine for the upcoming 2 influenza seasons
* Subject agrees not to seek vaccination with licensed influenza vaccines during the study
* Female subjects agree to use acceptable birth control for 6 weeks prior to first dose of vaccine until 1 month post Dose 3
Exclusion Criteria:
* Subject has a history of allergic reaction to the vaccine components
* Subject has has a fever within 3 days of screening
* Subject had a vaccination with an inactive virus within 14 days of Dose 1
* Subject had a vaccination with a live virus within 30 days of Dose 1
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
35 Years
Study:
NCT00851266
Study Brief:
Protocol Section:
NCT00851266